Literature DB >> 6424824

Carcinomatous meningitis diagnosed with monoclonal antibodies.

H B Coakham, E I Harper, J A Garson, B Brownell, E B Lane.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6424824      PMCID: PMC1441102          DOI: 10.1136/bmj.288.6426.1272

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


× No keyword cloud information.
  3 in total

1.  Monoclonal antibodies to identify tumour cells in CSF.

Authors:  W W Hancock; G Medley
Journal:  Lancet       Date:  1983-09-24       Impact factor: 79.321

2.  Biological characterization and clinical applications of a monoclonal antibody recognizing an antigen restricted to neuroectodermal tissues.

Authors:  P M Allan; J A Garson; E I Harper; U Asser; H B Coakham; B Brownell; J T Kemshead
Journal:  Int J Cancer       Date:  1983-05-15       Impact factor: 7.396

3.  Monoclonal antibodies provide specific intramolecular markers for the study of epithelial tonofilament organization.

Authors:  E B Lane
Journal:  J Cell Biol       Date:  1982-03       Impact factor: 10.539

  3 in total
  4 in total

1.  CSF cytology versus immunocytochemistry in meningeal carcinomatosis.

Authors:  W Boogerd; T M Vroom; P van Heerde; G Brutel de la Rivière; J L Peterse; J J van der Sande
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-01       Impact factor: 10.154

Review 2.  Monoclonal antibodies as reagents for brain tumour diagnosis: a review.

Authors:  H B Coakham; J A Garson; B Brownell; J T Kemshead
Journal:  J R Soc Med       Date:  1984-09       Impact factor: 5.344

3.  The role of monoclonal antibodies in brain tumour diagnosis and cerebrospinal fluid (CSF) cytology.

Authors:  J A Garson; H B Coakham; J T Kemshead; B Brownell; E I Harper; P Allan; S Bourne
Journal:  J Neurooncol       Date:  1985       Impact factor: 4.130

4.  Immunohistochemical analysis of the cerebrospinal fluid for carcinomatous and lymphomatous leptomeningitis.

Authors:  A Hovestadt; S C Henzen-Logmans; C J Vecht
Journal:  Br J Cancer       Date:  1990-10       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.